Evaluating barriers to and promotors of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs (Commentary).

Ranganathan, Sarath C

Ranganathan, Sarath C.

Afiliación

Ranganathan SC; Respiratory and Sleep Medicine, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, University of Melbourne, Melbourne, Australia; Infection and Immunity, Murdoch Children's Research Institute, Parkville, Victoria, Australia; Lung Foundation Australia, Melbourne, Australia. Electronic address: sarath.ranganathan@rch.org.au.

J Cyst Fibros ; 20 Suppl 3: 14-15, 2021 12.

Article en En | MEDLINE | ID: mdl-34503930

Asunto(s)

COVID-19; Fibrosis Quística; Telemedicina; Fibrosis Quística/epidemiología; Humanos; Pandemias; SARS-CoV-2

Palabras clave

COVID-19; Cystic fibrosis; Pandemic; Telehealth

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Telemedicina / Fibrosis Quística / COVID-19 Aspecto: Implementation_research Límite: Humans Idioma: En Revista: J Cyst Fibros Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google